Tenet Healthcare (NYSE:THC) EVP Sells $1,910,800.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Thomas Arnst sold 8,000 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the transaction, the executive vice president owned 12 shares of the company’s stock, valued at $2,866.20. The trade was a 99.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Tenet Healthcare Stock Down 1.4%

Shares of NYSE THC traded down $3.29 during trading hours on Tuesday, hitting $237.30. The company had a trading volume of 982,439 shares, compared to its average volume of 1,130,122. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm’s 50 day moving average is $210.94 and its 200-day moving average is $202.88. The stock has a market capitalization of $20.64 billion, a P/E ratio of 14.34, a price-to-earnings-growth ratio of 1.19 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same period in the prior year, the firm posted $3.44 earnings per share. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the business. Triumph Capital Management bought a new stake in Tenet Healthcare during the 3rd quarter valued at $25,000. Activest Wealth Management purchased a new position in shares of Tenet Healthcare in the fourth quarter valued at $26,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at $29,000. William B. Walkup & Associates Inc. bought a new position in Tenet Healthcare in the 3rd quarter worth about $32,000. Finally, Westside Investment Management Inc. grew its holdings in Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after buying an additional 96 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on THC shares. Morgan Stanley reiterated an “overweight” rating and issued a $260.00 price objective on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $265.00 price objective on shares of Tenet Healthcare in a research note on Monday, February 16th. Guggenheim raised their price objective on shares of Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a report on Friday, February 13th. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Finally, KeyCorp lifted their target price on Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Thursday, February 12th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.